These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15633954)

  • 1. Low-molecular-weight heparin use in special populations.
    Johnson PN; Smith KM
    Orthopedics; 2004 Dec; 27(12):1245-8. PubMed ID: 15633954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparin.
    Vanpee D; Gillet JB; Swine C
    Ann Emerg Med; 2000 Sep; 36(3):277-8. PubMed ID: 10969239
    [No Abstract]   [Full Text] [Related]  

  • 4. Low molecular weight heparins in special populations.
    Howard PA
    J Infus Nurs; 2003; 26(5):304-10. PubMed ID: 14506363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma anti-Xa monitoring for low-molecular-weight heparins in patients with chronic kidney disease.
    Gallieni M; Martini A; Granata A; Fusaro M
    Clin Pharmacokinet; 2010 Nov; 49(11):773-4. PubMed ID: 20923250
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulation in special patient populations: are special dosing considerations required?
    Michota F; Merli G
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S37-42. PubMed ID: 15853178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised evaluation of treatment modalities in thromboembolic disorders.
    ten Cate JW; Büller HR
    Haematologica; 1999 Jun; 84 Suppl EHA-4():85-7. PubMed ID: 10907478
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
    Valiukiene L; Naudziūnas A; Unikauskas A
    Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Low Molecular Weight Heparins for Venous Thromboembolism Prevention in Medical Patients-What Is New in 2019?
    Haas S
    Hamostaseologie; 2019 Feb; 39(1):62-66. PubMed ID: 30620990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular weight heparins.
    Talley JD
    J Ark Med Soc; 1997 Apr; 93(11):555-6. PubMed ID: 9114648
    [No Abstract]   [Full Text] [Related]  

  • 13. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thromboembolism among hospitalized medical patients.
    Goldhaber SZ; Turpie AG
    Circulation; 2005 Jan; 111(1):e1-3. PubMed ID: 15630031
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of venous thromboembolism: recommendations based on the International Consensus and the American College of Chest Physicians Sixth Consensus Conference on Antithrombotic Therapy.
    Haas S
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):171-7. PubMed ID: 11441977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolism in the obese pregnant woman.
    Liston F; Davies GA
    Semin Perinatol; 2011 Dec; 35(6):330-4. PubMed ID: 22108082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bridging anticoagulation].
    Schellong SM; Halbritter K; Haas S
    Chirurg; 2007 Feb; 78(2):125-6, 128-32. PubMed ID: 17252252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal long-term treatment of venous thromboembolism.
    Prandoni P
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):729-32. PubMed ID: 16170889
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of venous thromboembolism using only low-molecular-weight heparin?
    White RH
    Am J Med; 2001 Aug; 111(2):159-60. PubMed ID: 11498072
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thromboembolisms endanger the internist patients, too: who needs heparin].
    Bischoff A
    MMW Fortschr Med; 2006 Mar; 148(11):21-2. PubMed ID: 16612959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.